PEAK6 Investments’s Halozyme HALO Stock Holding History

PEAK6 Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,500	Closed	-$248K	–	4215
2023 Q1	$248K	Buy	+6,500	New	+$305K	﹤0.01%	2951
2020 Q3	–	Sell	-30,000	Closed	-$804K	–	4575
2020 Q2	$804K	Buy	+30,000	New	+$677K	﹤0.01%	2282
2020 Q1	–	Sell	-10,500	Closed	-$186K	–	4224
2019 Q4	$186K	Hold	10,500	–	–	﹤0.01%	2595
2019 Q3	$163K	Hold	10,500	–	–	﹤0.01%	3017
2019 Q2	$180K	Hold	10,500	–	–	﹤0.01%	2906
2019 Q1	$169K	Hold	10,500	–	–	﹤0.01%	3015
2018 Q4	$154K	Hold	10,500	–	–	﹤0.01%	3189
2018 Q3	$191K	Buy	+10,500	New	+$184K	﹤0.01%	3252

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's HALO Position: Q3 2023 in Review

PEAK6 Investments sold out of Halozyme (HALO) in Q3 2023, closing a stake of 266 shares — an estimated $10.9K sold.

PEAK6 Investments first reported a position in HALO in Q3 2018 and held it in 7 quarters. The position peaked at $23K in Q4 2018. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

PEAK6 Investments reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
PEAK6 Investments sold 266 Halozyme shares in Q3 2023, an estimated $10.9K.
PEAK6 Investments first reported a position in Halozyme in Q3 2018 and held it in 7 quarters.
PEAK6 Investments's Halozyme position peaked at $23K in Q4 2018.
389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.